Serum lipoproteins in type 2 diabetes mellitus
https://doi.org/10.14341/probl11626
Abstract
The qualitative and quantitative composition of serum lipoproteins was studied in patients with type 2 diabetes mellitus. A correlation analysis was made between lipid metabolic and other indices (Quetie index, a history of diabetes, the degree of its compensation, age, carbohydrate metabolism). The patients were found to have higher levels of atherogenic lipoprotein fractions [very low-density lipoproteins (VLDL) and low-density lipoproteins (LDL)], their lipid (cholesterol and triglycerides) and protein (apolipoprotein B) components being increased. On the contrary, the antiatherogenic fractions of high-density lipoproteins (HDL22 and HDL1) are decreased. The changes in the qualitative composition are associated with the higher levels of HDL triglycerides and with the lower levels of apoliprotein A-1. The correlation found between the content of lipoproteins of different classes and their components (proteins and lipids) and the indices of carbohydrate metabolism, the duration of disease, the body mass index, the stage of diabetes decompensation supports the hypothesis that the atherogenic lipoprotein fractions are involved in the etiology and pathogenesis of type 2 diabetes mellitus.
About the Authors
O. N. PoteryaevaResearch Institute of Biochemistry; Scientific Center for Clinical and Experimental Medicine
Russian Federation
L. Ye. Panin
Research Institute of Biochemistry; Scientific Center for Clinical and Experimental Medicine
Russian Federation
O. P. Shevkoplyas
Research Institute of Biochemistry; Scientific Center for Clinical and Experimental Medicine
Russian Federation
O. S. Voronova
Research Institute of Biochemistry; Scientific Center for Clinical and Experimental Medicine
Russian Federation
N. Ye. Kostina
Research Institute of Biochemistry; Scientific Center for Clinical and Experimental Medicine
Russian Federation
L. M. Polyakov
Research Institute of Biochemistry; Scientific Center for Clinical and Experimental Medicine
Russian Federation
References
1. Балаболкин М. И. Введение в диабстологию. - М., 1994.
2. Дедов И. И., Фадеев В. В. Введение в диабетологию. - М., 1998.
3. Денисенко Т. В. // Вопр. мед. химии. - 1991. - № 2. - С. 5-10.
4. Колб В. Г., Камышников В. С. Справочник по клинической химии. - Минск, 1982.
5. Курашвили Л. В., Семечкина Е. А., Адонина Т. С. и др. // Пробл. эндокринол. - 1998. - Т. 44, № 3. - С. 10-12.
6. Панин Л. Е., Останина Л. С., Атучина Н. В. // Бюл. экс- пер. биол. - 1994. - № 9. - С. 258-261.
7. Панин Л. Е., Останина Л. С., Колпаков А. Р. // Вопр. мед. химии. - 1995. - Т. 41, № 6. - С. 12-16.
8. Поляков Л. М., Панин Л. Е. // Лаб. дело. - 1975. - № 2. - С. 131-137.
9. Поляков Л. М., Потеряева О. Н., Панин Л. Е. // Там же. - 1991. - № 9. - С. 24-26.
10. Поляков Л. М., Потеряева О. Н., Панин Л. Е. // Вопр. мед. химии. - 1991. - Т. 37, № 1. - С. 89-92.
11. Ducobu J. // Диабетография. - 1997. - № 10. - С. 8.
12. Ни Z., Lu К, Мао Т. // Chung Hua Nei Ко Tsa Chill. - 1997. - Vol. 36, N 3. - P. 173-176.
13. Kaseta J. R., Skafar D. F., Ram J. L., Jacber S. J. // J. Clin. Endocrinol. Metab. - 1999. - Vol. 84, N 6. - P. 124-132.
14. Verges B. L. // Diabet. Metab. - 1999. - Vol. 25. - Suppl.3.- P. 32-40.
Review
For citations:
Poteryaeva O.N., Panin L.Ye., Shevkoplyas O.P., Voronova O.S., Kostina N.Ye., Polyakov L.M. Serum lipoproteins in type 2 diabetes mellitus. Problems of Endocrinology. 2003;49(4):4-8. https://doi.org/10.14341/probl11626

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).